Abstract:We have read with great interest a study reported by Kopytek et al1 titled “NETosis is associated with the severity of aortic stenosis: Links with inflammation.” In this study, the authors suggested that neutrophils play a critical role in the progression of aortic valve stenosis (AS). AS is prevalent in the elderly. Three primary processes including lipid accumulation, inflammation, and calcification are regarded to be involved in the pathophysiology of calcific aortic valve disease. Clinical studies provide evidence that inflammation initiates degenerative valve disease and valvular calcification. The inflammatory system, comprised specialized cells and mediators, is responsible for complex responses to all forms of AS at different stages.2 Inflammation in AS can be activated by leukocytes, macrophages, mast cells, fibroblasts, and endothelial cells. Previously, neutrophils have not been considered in the pathophysiology of atherosclerosis. However, recent studies have demonstrated that an increased ratio of neutrophils to lymphocytes was related to the severity of calcific AS in patients, and current evidence suggests a contributory role of neutrophils in the progression of AS.3 Interestingly, this human study provides the direct evidence that neutrophils may contribute to the progression of AS. AS has a close association with atherosclerosis, similarly in the progression of chronic inflammation. Because of their relatively short lifespans, neutrophils have received little attention in the pathophysiology of atherosclerosis. Over the past decades, however, advances in techniques have allowed for more sensitive detection of neutrophils in atherosclerotic plaque specimens. This has allowed for investigations into the exact mechanistic role of neutrophils in atherosclerotic lesions.4 Similarly, several mechanistic roles of neutrophils in the development of AS should be considered as follows (Fig. 1).5 First, neutrophils aggravate endothelial dysfunction by inducing changes in endothelial permeability. Elevated lipid levels activate prime neutrophils, which may then secrete the radical species and granule proteins, subsequently inducing endothelial dysfunction. Endothelial dysfunction enhances adhesive cytokine expression and increases leakiness. Second, neutrophils favor the recruitment of monocytes to the aortic valve. It has been shown that neutrophil-derived cytokine enhancement could increase expression of cell adhesion molecules and subsequently increase adhesion of monocytes. Third, neutrophils activate macrophages and promote macrophage polarization. Macrophages participate in the progression of AS at all stages. Neutrophils not only promote macrophage maturation, but also induce the M1 macrophage phenotype. Furthermore, neutrophils promote normal matrix degradation and fibrosis formation. Neutrophil elastase and MMPs secreted by neutrophils may promote cellular proliferation and extracellular matrix remodeling by acting on valvular fibroblasts. Finally, the neutrophil–lymphocyte ratio is associated with coronary artery calcification.6 However, further studies are needed to determine whether neutrophils play a direct role in the calcification.FIGURE 1.: Neutrophils feed mechanisms of aortic valve stenosis. IL-1, interleukin-1; IL-6, interleukin-6; LDL, low-density lipoprotein; MPO, myeloperoxidase; TNF-alpha, tumor necrosis factor-alpha.Taken together, neutrophils affect the progression of AS at all stages with a mechanism similar to mechanisms of inflammation.

Nitric Oxide-Donating Atorvastatin Attenuates Neutrophil Recruitment During Vascular Inflammation Independent of Changes in Plasma Cholesterol

Influence of atorvastatin on ion pump activity of smooth muscle cells and intima proliferation after arterial intimal injury

The Neglected Role of Neutrophils in the Severity of Aortic Valve Stenosis

[Effects of Atorvastatin on Endothelium Protection in Spontaneously Hypertensive Rats].

Nitric oxide-donating statin improves multiple functions of circulating angiogenic cells

High-dose atorvastatin and rosuvastatin reduce the levels of neutrophil extracellular trap-related proteins in coronary artery disease: association with prothrombotic state

Anti-atherogenic effects of montelukast associated with reduced MCP-1 expression in a rabbit carotid balloon injury model.

Atorvastatin reduces plaque vulnerability in an atherosclerotic rabbit model by altering the 5-lipoxygenase pathway.

Nicotinic acid inhibits vascular inflammation via the SIRT1-dependent signaling pathway

Lovastatin Increases Nitric Oxide Synthesis in IL-1 Beta-Stimulated Smooth Muscle Cells.

Early atorvastatin administration suppresses the oxygen-activating ability of rat neutrophils during monocrotalinin-induced pulmonary arterial hypertension (PAH)

Neutrophil Superoxide Anion Generation During Atorvastatin and Fluvastatin Therapy Used in Coronary Heart Disease Primary Prevention

Modulation of Nitric Oxide Synthases by Oxidized LDLs: Role in Vascular Inflammation and Atherosclerosis Development

Diet induced mild hypercholesterolemia in pigs: local and systemic inflammation, effects on vascular injury - rescue by high-dose statin treatment

Proteomic Analysis of Endothelial Lipid Rafts Reveals a Novel Role of Statins in Antioxidation.

The high-dose statin treatment reduces neutrophil extracellular traps formation in patients with coronary artery disease

Atorvastatin inhibits Lipopolysaccharide (LPS)-induced vascular inflammation to protect endothelium by inducing Heme Oxygenase-1 (HO-1) expression

Atorvastatin inhibits pro-inflammatory actions of aldosterone in vascular smooth muscle cells by reducing oxidative stress

Anti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109A dependent mechanisms

Abstract 242: A Novel Transient Receptor Potential Ion Channel Vanilloid 4 Agonist Inhibits Monocytes Adhesion and Atherosclerosis Via Enos Activation

Atorvastatin Improves Plaque Stability In Apoe-Knockout Mice By Regulating Chemokines And Chemokine Receptors